Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (21988)	6/8/1998 11:37:00 AM
From: tonyt	Respond to of 32384

>Lastly, I ask once again what makes you think that you can access >information I may or may not tell Henry? When did I say that? As I already told you, I was talking about information that henry attributed to bernie. Are you the bernie that henry referred to when he stated that "I just heard from Bernie LGND plans to change (sic) about $40,000 for a course of (sic) ONTAK to treat CTCL and they are looking at non-Hodgkin lymphoma applications for ONTAK." Or is this a different bernie? --Tony